TrialFrontiers in pharmacology2026

Pharmacokinetics and safety of SHR0302, a selective JAK1 inhibitor, in Chinese patients with hepatic impairment.

Jiajia Mai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.